PRESS DIGEST - Wall Street Journal - May 25
May 25 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Oct 7 Kite Pharma Inc :
* Kite Pharma Inc says encouraged that complete remission rate of 43 percent in phase 1 portion of study continues through month 12
* Co plans to report additional data on durability of response to KTE-C19 from phase 2 portion of ZUMA-1 in 2017
* Month follow-up data from ZUMA-1 phase 1 at the european society for medical oncology (ESMO) annual congress
* Kte-C19 related adverse events consisted predominantly of cytokine release syndrome (CRS) and neurotoxicity which were generally reversible Source text for Eikon: Further company coverage:
SAN FRANCISCO, May 24 Infosys Ltd, the India-based computer services giant, on Wednesday touted its new strategy to hire and train 10,000 American workers over the next two years at the company's annual leadership meeting in San Francisco.
DUBAI, May 25 Here are some factors that may affect Middle East stock markets on Thursday. Reuters has not verified the press reports and does not vouch for their accuracy.